Stemline Therapeutics Inc (NASDAQ:STML)

14.47
Delayed Data
As of Mar 31
 -0.61 / -4.05%
Today’s Change
10.50
Today|||52-Week Range
21.28
-15.18%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Hoberman Kenneth
Chief Operating Officer
Sale3/19/201517,307$16.43$284.4K-10.57%
Hoberman Kenneth
Chief Operating Officer
Sale5/21/201415,250$13.32$203.1K+8.96%
Bergstein Ivan
Chief Executive Officer
Sale11/26/201411,974$14.40$172.4K-2.16%
Rowinsky Eric K
Chief Medical Officer
Sale4/25/201410,879$15.01$163.3K-2.56%
Hoberman Kenneth
Chief Operating Officer
Buy3/19/201527,105$4.09$110.9K-10.57%
Gionco David G
Chief Accounting Officer
Sale1/20/20153,311$14.22$47.1K+1.40%
Bergstein Ivan
Chief Executive Officer
Sale2/18/20153,180$14.02$44.6K+2.77%
Rowinsky Eric K
Chief Medical Officer
Sale2/18/20151,640$13.99$22.9K+2.77%
Bentsur Ronald
Director
Sale3/18/20151,388$16.12$22.4K-9.17%
Hoberman Kenneth
Chief Operating Officer
Sale2/18/20151,593$14.02$22.3K+2.77%
Page of 2

To view my watchlist

Not a member yet?

Sign up now for a free account